0CF Stock Chart & Stats
€0.13
€0.00(0.00%)
At close: 4:00 PM EST
€0.13
€0.00(0.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.19
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€3.98M
Enterprise Value€130.45
Total Cash (Recent Filing)€480.00K
Total Debt (Recent Filing)€78.56M
Price to Earnings (P/E)―
Beta2.31
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding183,219,120
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)11.75
Price to Sales (P/S)1.68
P/FCF Ratio-16.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.01
Revenue Forecast (FY)€10.38M
Bulls Say, Bears Say
Bulls Say
Bio-based Chemistry PlatformThe proprietary bio-based chemistry platform is aligned with the structural shift toward replacing fossil-based and hazardous inputs. Applications across wood, textiles, and material treatments provide multiple routes for adoption, supporting potential long-term relevance beyond a single product.
Moderating Cash BurnAlthough cash generation remains negative, the reduced free-cash outflow indicates some improvement in financial discipline or operating performance. If sustained, slower cash consumption could extend funding runway and reduce the urgency of external financing over the coming quarters.
Loss Improvement From 2022Improvement from the exceptionally weak 2022 loss level shows that the business has demonstrated some capacity to reduce losses over time. This provides a foundation for future operating leverage, although continued execution is needed to reach sustainable profitability.
Bears Say
Declining Revenue And Deep LossesFalling revenue combined with deeply negative operating and net margins indicates that the current business base is not yet supporting a sustainable earnings model. Continued losses can restrict investment, weaken equity, and make future growth increasingly dependent on external funding.
Very High LeverageDebt substantially exceeds the company’s equity base, leaving limited balance-sheet flexibility if operations remain loss-making. High leverage increases refinancing and dilution risk, while interest and repayment obligations can constrain investment in commercialization and future growth.
Negative Operating Cash FlowPersistent negative operating and free cash flow means the business is not currently self-funding its operations and investment needs. This limits financial resilience, particularly alongside elevated leverage, and makes dependable conversion of products into cash a key unresolved requirement.
OrganoClick AB News
0CF FAQ
What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was <€0.01 and its highest was €0.19 in the past 12 months.
What is OrganoClick AB’s market cap?
OrganoClick AB’s market cap is €3.98M.
When is OrganoClick AB’s upcoming earnings report date?
OrganoClick AB’s upcoming earnings report date is Nov 05, 2026 which is in 48 days.
How were OrganoClick AB’s earnings last quarter?
OrganoClick AB released its earnings results on Aug 12, 2026. The company reported -€0.003 earnings per share for the quarter.
Is OrganoClick AB overvalued?
According to Wall Street analysts OrganoClick AB’s price is currently Overvalued.
Does OrganoClick AB pay dividends?
OrganoClick AB does not currently pay dividends.
What is OrganoClick AB’s EPS estimate?
OrganoClick AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OrganoClick AB have?
OrganoClick AB has 183,219,120 shares outstanding.
What happened to OrganoClick AB’s price movement after its last earnings report?
OrganoClick AB reported an EPS of -€0.003 in its last earnings report. Following the earnings report the stock price went up 17.857%.
Which hedge fund is a major shareholder of OrganoClick AB?
Currently, no hedge funds are holding shares in DE:0CF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OrganoClick AB
OrganoClick AB (publ), a technology firm based in Täby, Sweden, was established in 2006. The company specializes in the development, production, and sale of innovative fiber-based materials and chemicals for applications spanning wood treatment, technical textiles, nonwovens, and biocomposites. Its diverse product portfolio includes OrganoWood, a wood preservation system that enhances wood's resistance to both rot and fire, primarily serving the construction industry and consumers. OrganoTex offers a biodegradable durable water repellent (DWR) technology for textiles, alongside related shoe and clothing care items. Additionally, OrganoComp is a biobased, plastic-free, and compostable composite designed to replace rigid plastics in 3D-molded products. For consumers, the BIOkleen brand provides a range of maintenance and cleaning solutions for wood, facades, roofs, terraces, and car care. Industrial clients benefit from OC-BioBinder, a biodegradable and plastic-free binder used in nonwovens and technical textiles as an alternative to conventional plastic binders, and OC-AquaSil Tex, a biodegradable water-repelling product that replaces PFAS chemicals in nonwovens, specialty papers, and technical textiles.
Technical Analysis
Hexpol AB
―
Nexam Chemical Holding AB
―
Svenska Aerogel Holding AB
―
Polygiene AB
―
Photocat A/S
―